§ 58-65-93. Coverage for prostate-specific antigen (PSA) tests.
§58‑65‑93. Coverage for prostate‑specific antigen (PSA)tests.
(a) Every insurancecertificate or subscriber contract under any hospital service plan or medicalservice plan governed by this Article and Article 66 of this Chapter, and everypreferred provider benefit plan under G.S. 58‑50‑56, that isissued, renewed, or amended on or after January 1, 1994, shall provide coveragefor prostate‑specific antigen (PSA) tests or equivalent tests for thepresence of prostate cancer. The same deductibles, coinsurance, and otherlimitations as apply to similar services covered under the certificate orcontract shall apply to coverage for prostate‑specific antigen (PSA)tests or equivalent tests for the presence of prostate cancer.
(b) As used in thissection, "prostate‑specific antigen (PSA) tests or equivalent testsfor the presence of prostate cancer" means serological tests fordetermining the presence of prostate cytoplasmic protein (PSA) and thegeneration of antibodies to it, as a novel marker for prostatic disease.
(c) Coverage forprostate‑specific antigen (PSA) tests or equivalent tests for thepresence of prostate cancer shall be provided when recommended by a physician. (1993,c. 269, s. 2; 1997‑519, s. 3.7.)